Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)
Titel:
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)
Auteur:
Wassmann, Barbara Pfeifer, Heike Goekbuget, Nicola Beelen, Dietrich W. Beck, Joachim Stelljes, Matthias Bornhäuser, Martin Reichle, Albrecht Perz, Jolanta Haas, Rainer Ganser, Arnold Schmid, Mathias Kanz, Lothar Lenz, Georg Kaufmann, Martin Binckebanck, Anja Brück, Patrick Reutzel, Regina Gschaidmeier, Harald Schwartz, Stefan Hoelzer, Dieter Ottmann, Oliver G.